Acadia Pharmaceuticals | Passifs Courants



Current Liabilities Changement Date
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
ALKERMES USD 443.73M 21.47M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Cytokinetics USD 159.73M 19.95M 2025-03
Eisai JPY 372.29B 9.32B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Incyte USD 1.89B 244.96M 2025-03
J&J USD 56.9B 6.58B 2025-03
Moderna USD 1.6B 602M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Prothena USD 48.5M 2.08M 2024-12
PTC Therapeutics USD 595.39M 14.41M 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Acadia Pharmaceuticals Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.